{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:32:33Z","timestamp":1726515153214},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.xphs.2017.01.032","type":"journal-article","created":{"date-parts":[[2017,2,3]],"date-time":"2017-02-03T15:16:27Z","timestamp":1486134987000},"page":"1396-1404","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats"],"prefix":"10.1016","volume":"106","author":[{"given":"Yu","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Milavetz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret O.","family":"James","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guohua","family":"An","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2017.01.032_bib1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.3109\/03602539808996323","article-title":"Pharmacokinetics, metabolism and toxicology of dichloroacetate","volume":"30","author":"Stacpoole","year":"1998","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.xphs.2017.01.032_bib2","first-page":"617","article-title":"Dichloroacetate and cancer: new home for an orphan drug?","volume":"1846","author":"Kankotia","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.xphs.2017.01.032_bib3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.pharmthera.2016.10.018","article-title":"Therapeutic applications of dichloroacetate and the role of glutathione transferase zeta-1","volume":"170","author":"James","year":"2016","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.xphs.2017.01.032_bib4","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1056\/NEJM197803092981002","article-title":"Metabolic effects of dichloroacetate in patients with diabetes mellitus and hyperlipoproteinemia","volume":"298","author":"Stacpoole","year":"1978","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.xphs.2017.01.032_bib5","doi-asserted-by":"crossref","first-page":"e1223","DOI":"10.1542\/peds.2007-2062","article-title":"Evaluation of long-term treatment of children with congenital lactic acidosis with dichloroacetate","volume":"121","author":"Stacpoole","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.xphs.2017.01.032_bib6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1542\/peds.2005-1226","article-title":"Controlled clinical trial of dichloroacetate for treatment of congenital lactic acidosis in children","volume":"117","author":"Stacpoole","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.xphs.2017.01.032_bib7","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1177\/0091270003251392","article-title":"Population kinetics, efficacy, and safety of dichloroacetate for lactic acidosis due to severe malaria in children","volume":"43","author":"Agbenyega","year":"2003","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib8","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1177\/0091270006292627","article-title":"Human kinetics of orally and intravenously administered low-dose 1,2-(13)C-dichloroacetate","volume":"46","author":"Jia","year":"2006","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/sj.bjc.6604554","article-title":"Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer","volume":"99","author":"Michelakis","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.xphs.2017.01.032_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s10637-015-0221-y","article-title":"A\u00a0phase I open-labeled, single-arm, dose-escalation, study of dichloroacetate (DCA) in patients with advanced solid tumors","volume":"33","author":"Chu","year":"2015","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.xphs.2017.01.032_bib11","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00432-014-1583-9","article-title":"Dichloroacetate should be considered with platinum-based chemotherapy in hypoxic tumors rather than as a single agent in advanced non-small cell lung cancer","volume":"140","author":"Garon","year":"2014","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.xphs.2017.01.032_bib12","first-page":"207","article-title":"Drinking water disinfection byproducts: review and approach to toxicity evaluation","volume":"107","author":"Boorman","year":"1999","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.xphs.2017.01.032_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1289\/ehp.1002554","article-title":"The dichloroacetate dilemma: environmental hazard versus therapeutic goldmine\u2013both or neither?","volume":"119","author":"Stacpoole","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.xphs.2017.01.032_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/bdd.2510120507","article-title":"Disposition and pharmacodynamics of dichloroacetate (DCA) and oxalate following oral DCA doses","volume":"12","author":"Curry","year":"1991","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.xphs.2017.01.032_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1289\/ehp.02110757","article-title":"Low-dose pharmacokinetics and oral bioavailability of dichloroacetate in naive and GST-zeta-depleted rats","volume":"110","author":"Saghir","year":"2002","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.xphs.2017.01.032_bib16","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/toxsci\/kfh276","article-title":"A\u00a0quantitative description of suicide inhibition of dichloroacetic acid in rats and mice","volume":"82","author":"Keys","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.xphs.2017.01.032_bib17","first-page":"1134","article-title":"Pharmacokinetics and metabolism of [14C]dichloroacetate in male Sprague-Dawley rats. Identification of glycine conjugates, including hippurate, as urinary metabolites of dichloroacetate","volume":"26","author":"James","year":"1998","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.xphs.2017.01.032_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/jbt.21518","article-title":"Pharmacokinetics of oral dichloroacetate in dogs","volume":"27","author":"Maisenbacher","year":"2013","journal-title":"J\u00a0Biochem Mol Toxicol"},{"key":"10.1016\/j.xphs.2017.01.032_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.tox.2007.12.010","article-title":"Quantitative evaluation of dichloroacetic acid kinetics in human\u2014a physiologically based pharmacokinetic modeling investigation","volume":"245","author":"Li","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.xphs.2017.01.032_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/taap.1997.8190","article-title":"A\u00a0physiologically based pharmacokinetic model for trichloroethylene and its metabolites, chloral hydrate, trichloroacetate, dichloroacetate, trichloroethanol, and trichloroethanol glucuronide in B6C3F1 mice","volume":"147","author":"Abbas","year":"1997","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib21","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0378-4347(97)00404-0","article-title":"Determination of dichloroacetate and its metabolites in human plasma by gas chromatography-mass spectrometry","volume":"703","author":"Yan","year":"1997","journal-title":"J\u00a0Chromatogr B Biomed Sci"},{"key":"10.1016\/j.xphs.2017.01.032_bib22","first-page":"16","article-title":"Preparation and stability of intravenous solutions of sodium dichloroacetate (DCA)","volume":"46","author":"Chu","year":"1992","journal-title":"J\u00a0Parenter Sci Technol"},{"year":"1989","series-title":"NONMEM User's Guides","author":"Beal","key":"10.1016\/j.xphs.2017.01.032_bib23"},{"key":"10.1016\/j.xphs.2017.01.032_bib24","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cmpb.2003.11.003","article-title":"Perl-speaks-NONMEM (PsN)\u2013a Perl module for NONMEM related programming","volume":"75","author":"Lindbom","year":"2004","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.xphs.2017.01.032_bib26","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1021\/tx990085l","article-title":"Inactivation of glutathione transferase zeta by dichloroacetic acid and other fluorine-lacking alpha-haloalkanoic acids","volume":"12","author":"Anderson","year":"1999","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.xphs.2017.01.032_bib27","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/15287399309531697","article-title":"Tissue distribution, excretion, and urinary metabolites of dichloroacetic acid in the male Fischer 344 rat","volume":"38","author":"Lin","year":"1993","journal-title":"J\u00a0Toxicol Environ Health"},{"key":"10.1016\/j.xphs.2017.01.032_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/0041-008X(92)90332-M","article-title":"Metabolism and lipoperoxidative activity of trichloroacetate and dichloroacetate in rats and mice","volume":"115","author":"Larson","year":"1992","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib29","first-page":"465","article-title":"Complex PK\/PD models\u2013an alcoholic experience","volume":"35","author":"Holford","year":"1997","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.xphs.2017.01.032_bib30","series-title":"The Influence of Body Composition on Ethanol Pharmacokinetics Using a Rate Dependent Extraction Model","first-page":"24","author":"Holford","year":"2015"},{"year":"1988","series-title":"Reference Physiological Parameters in Pharmacokinetic Modeling","author":"Arms","key":"10.1016\/j.xphs.2017.01.032_bib31"},{"key":"10.1016\/j.xphs.2017.01.032_bib32","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1177\/074823379701300401","article-title":"Physiological parameter values for physiologically based pharmacokinetic models","volume":"13","author":"Brown","year":"1997","journal-title":"Toxicol Ind Health"},{"key":"10.1016\/j.xphs.2017.01.032_bib33","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/BF01059688","article-title":"Hepatic clearance of drugs. I. Theoretical considerations of a \u201cwell-stirred\u201d model and a \u201cparallel tube\u201d model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance","volume":"5","author":"Pang","year":"1977","journal-title":"J\u00a0Pharm Biopharm"},{"key":"10.1016\/j.xphs.2017.01.032_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2125.2004.02321.x","article-title":"A\u00a0semiphysiological pharmacokinetic model for artemisinin in healthy subjects incorporating autoinduction of metabolism and saturable first-pass hepatic extraction","volume":"59","author":"Gordi","year":"2005","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib35","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.276.5309.122","article-title":"A\u00a0general model for the origin of allometric scaling laws in biology","volume":"276","author":"West","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.xphs.2017.01.032_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cmpb.2007.12.002","article-title":"Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: the npde add-on package for R","volume":"90","author":"Comets","year":"2008","journal-title":"Comput Methods Programs Biomed"},{"key":"10.1016\/j.xphs.2017.01.032_bib37","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0076-6879(05)01004-9","article-title":"Human glutathione transferase zeta","volume":"401","author":"Board","year":"2005","journal-title":"Meth Enzymol"},{"key":"10.1016\/j.xphs.2017.01.032_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/taap.1999.8698","article-title":"Comparative toxicokinetics of chlorinated and brominated haloacetates in F344 rats","volume":"158","author":"Schultz","year":"1999","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib39","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1016\/j.bcp.2003.07.002","article-title":"Pharmacologic or genetic ablation of maleylacetoacetate isomerase increases levels of toxic tyrosine catabolites in rodents","volume":"66","author":"Ammini","year":"2003","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.xphs.2017.01.032_bib40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1124\/jpet.107.134593","article-title":"Age-dependent kinetics and metabolism of dichloroacetate: possible relevance to toxicity","volume":"324","author":"Shroads","year":"2008","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.xphs.2017.01.032_bib41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1021\/tx990175q","article-title":"Polymorphism- and species-dependent inactivation of glutathione transferase zeta by dichloroacetate","volume":"13","author":"Tzeng","year":"2000","journal-title":"Chem Res Toxicol"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917300667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354917300667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T10:05:32Z","timestamp":1582538732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354917300667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S0022354917300667"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2017.01.032","relation":{},"ISSN":["0022-3549"],"issn-type":[{"type":"print","value":"0022-3549"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Mechanism-Based Pharmacokinetic Enzyme Turnover Model for Dichloroacetic Acid Autoinhibition in Rats","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2017.01.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}